3. 结构
3.1 二维结构
3.2 三维结构
-1
-2
-3
29 31 0 0 0 0 0 0 0999 V2000
0.5376 3.2226 -0.7359 Cl 0 0 0 0 0 0 0 0 0 0 0 0
2.7392 -2.5586 0.9460 S 0 0 0 0 0 0 0 0 0 0 0 0
-2.9025 1.4386 1.4870 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.7523 -0.2748 -0.0867 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.5141 0.5644 0.2634 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.0012 -1.1917 -1.2321 N 0 0 0 0 0 0 0 0 0 0 0 0
1.3515 -1.6583 0.7985 N 0 0 0 0 0 0 0 0 0 0 0 0
3.8796 -1.4560 0.4545 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.3695 -1.2947 -0.8947 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2167 -1.9088 -1.6577 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3741 -0.2988 -0.3589 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8681 0.6457 0.0854 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.4356 0.5678 0.7980 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7260 -0.4475 0.3549 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4933 1.8179 -0.3728 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2165 -0.3283 0.1521 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.9274 0.3513 0.8743 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8909 1.9297 -0.5629 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7904 0.8796 -0.3122 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.1109 -0.8444 -1.5624 H 1 0 0 0 0 0 0 0 0 0 0 0
-3.8737 -2.0249 -0.2538 H 1 0 0 0 0 0 0 0 0 0 0 0
-2.3542 -1.8005 -2.7386 H 1 0 0 0 0 0 0 0 0 0 0 0
-2.1170 -2.9760 -1.4338 H 1 0 0 0 0 0 0 0 0 0 0 0
-0.9078 1.3308 0.8006 H 0 0 0 0 0 0 0 0 0 0 0 0
-5.1460 -0.6632 1.2172 H 0 0 0 0 0 0 0 0 0 0 0 0
-5.3861 0.5263 -0.1022 H 0 0 0 0 0 0 0 0 0 0 0 0
-5.3612 1.0570 1.5893 H 0 0 0 0 0 0 0 0 0 0 0 0
3.3074 2.8712 -0.9216 H 0 0 0 0 0 0 0 0 0 0 0 0
4.8567 0.9960 -0.4676 H 0 0 0 0 0 0 0 0 0 0 0 0
1 15 1 0 0 0 0
2 7 1 0 0 0 0
2 8 1 0 0 0 0
3 13 2 0 0 0 0
4 9 1 0 0 0 0
4 11 1 0 0 0 0
4 13 1 0 0 0 0
5 11 1 0 0 0 0
5 12 1 0 0 0 0
5 24 1 0 0 0 0
6 10 1 0 0 0 0
6 11 2 0 0 0 0
7 14 2 0 0 0 0
8 16 2 0 0 0 0
9 10 1 0 0 0 0
9 20 1 0 0 0 0
9 21 1 0 0 0 0
10 22 1 0 0 0 0
10 23 1 0 0 0 0
12 14 1 0 0 0 0
12 15 2 0 0 0 0
13 17 1 0 0 0 0
14 16 1 0 0 0 0
15 18 1 0 0 0 0
16 19 1 0 0 0 0
17 25 1 0 0 0 0
17 26 1 0 0 0 0
17 27 1 0 0 0 0
18 19 2 0 0 0 0
18 28 1 0 0 0 0
19 29 1 0 0 0 0
M ISO 4 20 2 21 2 22 2 23 2
4. 国际命名与标识
4.1 IUPAC Name
1-[2-[(5-chloro-2,1,3-benzothiadiazol-4-yl)amino]-4,4,5,5-tetradeuterioimidazol-1-yl]ethanone
4.2 InChl
InChI=1S/C11H10ClN5OS/c1-6(18)17-5-4-13-11(17)14-9-7(12)2-3-8-10(9)16-19-15-8/h2-3H,4-5H2,1H3,(H,13,14)/i4D2,5D2
4.3 InChlKey
NBGDKTHDTLEUQJ-CQOLUAMGSA-N
4.4 Canonical SMILES
CC(=O)N1CCN=C1NC2=C(C=CC3=NSN=C32)Cl
4.5 lsomeric SMILES
[2H]C1(C(N(C(=N1)NC2=C(C=CC3=NSN=C32)Cl)C(=O)C)([2H])[2H])[2H]
4.6 SDF文件
5. 波谱数据
5.1 13C核磁共振谱(13C NMR)
5.2 1H核磁共振谱(1H NMR)
5.3 质谱(MS)
5.4 红外光谱(IR)
5.5 紫外/可见光谱(UV/Vis)
6. 相关药材
7. 相关靶点
8. 相关疾病